{"transactions":[{"id":707190,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T21:00:05.000Z","date":"2026-03-31","kind":"other","planned":false,"acquired":true,"shares":0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"date","element":"transactionDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported grant was made in error and has been cancelled."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001683168-26-005621","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826005621/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-02"}},{"id":820568,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:16:53.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":119170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis."}],"balance_after":119170,"derivative":{"exercise_price":0.67,"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":119170},"source":{"system":"sec-edgar","filing":"0001683168-26-002630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826002630/ownership.xml","form_type":"4"}},{"id":971642,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T22:06:55.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":63233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis. This transaction is late due to an inadvertent administrative error and not any error of Mr. Abecassis."}],"balance_after":63233,"derivative":{"exercise_price":1.22,"expiration_date":"2035-04-24","underlying":"Common Stock","underlying_shares":63233},"source":{"system":"sec-edgar","filing":"0001683168-25-009112","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009112/ownership.xml","form_type":"4"}},{"id":971641,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:06:55.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":16875,"price":1.02,"value":17212.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":22292,"source":{"system":"sec-edgar","filing":"0001683168-25-009112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009112/ownership.xml","form_type":"4"}},{"id":971640,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:06:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39167,"source":{"system":"sec-edgar","filing":"0001683168-25-009112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009112/ownership.xml","form_type":"4"}},{"id":1452867,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-17T20:58:35.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":38009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis. This transaction is late due to an inadvertent administrative error and not any error of Mr. Abecassis."}],"balance_after":38009,"derivative":{"exercise_price":2.12,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":38009},"source":{"system":"sec-edgar","filing":"0001683168-24-004915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316824004915/ownership.xml","form_type":"4"}},{"id":1731596,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T22:00:10.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":61248,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61248,"derivative":{"exercise_price":2.18,"exercise_date":"2023-11-20","expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":61248},"source":{"system":"sec-edgar","filing":"0001683168-23-008429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316823008429/ownership.xml","form_type":"4"}}]}